← all drugs
Adalimumab-adaz Injection
being discontinued · Rheumatology · Snapshot: 2026-10-09
- Manufacturers listed
- Sandoz Inc.
- Machine-readable
- JSON for this drug
Presentations (5)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Hyrimoz, Injection, Kit (NDC 61314-517-36) | Sandoz Inc. | unknown | 01/13/2026 |
| Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-68) | Sandoz Inc. | unknown | 01/13/2026 |
| Hyrimoz, Injection, 40 mg/.4 mL (NDC 61314-473-64) | Sandoz Inc. | unknown | 01/13/2026 |
| Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-36) | Sandoz Inc. | unknown | 01/13/2026 |
| Hyrimoz, Injection, Kit (NDC 61314-531-64) | Sandoz Inc. | unknown | 01/13/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.